Bruker Announces Major Advancements at AGBT to Enable Complete High-Fidelity Spatial Biology Across the Biological Spectrum
Bruker Corporation (BRKR)
Last bruker corporation earnings: 10/31 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.bruker.com/investors/default.aspx
Company Research
Source: Business Wire
Portfolio innovations include the launch of the new CellScape XR spatial proteomics platform, the unique CosMx mouse whole transcriptome panel, the launch of the PaintScape platform for 3D genome visualization, extensive multiomics GeoMx capabilities, and AI-ready AtoMx analysis ORLANDO, Fla.--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) announced today significant portfolio advancements from Bruker Spatial Biology to be unveiled at the 2026 Advances in Genome Biology and Technology (AGBT) General Meeting. These updates highlight Bruker’s category leadership in spatial biology and its commitment to delivering best-in-class solutions across DNA, RNA, and protein. The Bruker Spatial Biology division will launch several new products, introduce expanded capabilities, and demonstrate a strong innovation roadmap that extends its technical leadership in each spatial platform, and further integrates multiomics across platforms to accelerate scientific insights — from discovery throug
Show less
Read more
Impact Snapshot
Event Time:
BRKR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BRKR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BRKR alerts
High impacting Bruker Corporation news events
Weekly update
A roundup of the hottest topics
BRKR
News
- Bruker Advances Functional Proteomics 2.0 with timsOmniTM Mass Spectrometry Proteoform Analysis for Deeper Insights into Disease BiologyBusiness Wire
- 3D Protein Structure Analysis Market Report 2026 Featuring Profiles of Merck, Bruker Corp., Thermo Fisher Scientific, JEOL, Spectris and Other Leading Players [Yahoo! Finance]Yahoo! Finance
- Bruker (NASDAQ:BRKR) had its price target lowered by analysts at TD Cowen from $53.00 to $43.00. They now have a "hold" rating on the stock.MarketBeat
- Bruker (NASDAQ:BRKR) had its "neutral" rating reaffirmed by analysts at UBS Group AG.MarketBeat
- Bruker (NASDAQ:BRKR) had its "sell" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..MarketBeat
BRKR
Earnings
- 2/12/26 - Miss
BRKR
Sec Filings
- 2/20/26 - Form 8-K
- 2/18/26 - Form 4
- 2/18/26 - Form 4
- BRKR's page on the SEC website